REQUEST A DEMO
Total
USD $0.00
Search more companies

Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Lessors of Real Estate | Office Administrative Services | All Other Miscellaneous Ambulatory Health Care Services
Full name: Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A. Profile Updated: June 03, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A. is based in Poland. The head office is in Olsztyn. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was first established on February 18, 2022.

Headquarters
Ul. 1 Maja 13/C
Olsztyn; Warminsko-Mazurskie; Postal Code: 10-117

Contact Details: Purchase the Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A. report to view the information.

Website: http://www.etykaosrodek.pl

Basic Information
Outstanding Shares:
Purchase the Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A. report to view the information.
Registered Capital:
Purchase the Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A. report to view the information.
Incorporation Date:
February 18, 2022
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Associate Partner
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
No results were found for this company.

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?